Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171692612> ?p ?o ?g. }
- W3171692612 endingPage "613" @default.
- W3171692612 startingPage "605" @default.
- W3171692612 abstract "The newer adenosine diphosphate (ADP) receptor blockers ticagrelor and prasugrel are superior to clopidogrel in the long-term management of acute coronary syndrome (ACS). We evaluated the acute performance (prehospital loading) of these ADP receptor blockers in a primary percutaneous coronary intervention (PCI) for an ST-elevation myocardial infarction (STEMI). In a retrospective, single-center registry study, data on all STEMI patients admitted for their first primary PCI between January 2007 and April 2020 were analyzed (n = 3218). The three ADP receptor blockers were mainly used during consecutive periods (clopidogrel 2007–2010, prasugrel 2011–2014, and ticagrelor 2014–2020), and were compared with risk factor-adjusted multivariate logistic regression for acute 3- and 7-day mortality and culprit artery flow before and after PCI. Of the 3218 total patients, 47.6% (n = 1532) were treated with ticagrelor, 22.1% (n = 711) were treated with prasugrel, and 30.3% (n = 975) were treated with clopidogrel. The use of ticagrelor or prasugrel as opposed to clopidogrel was associated with better culprit artery flow before PCI (odds ratio [OR] 1.21 for moderate or good flow, 95% confidence interval [CI] 1.03–1.42, p = 0.022), as well as lower acute mortality (OR 0.66 for 3-day mortality, 95% CI 0.46–0.95, p = 0.025; and OR 0.71 for 7-day mortality, 95% CI 0.52–0.98, p = 0.039). The results in regard to acute mortality were highlighted among patients with short treatment delays (disappearing with longer treatment delays; p < 0.05 for interaction). The newer ADP receptor blockers are associated with lower mortality and better culprit artery flow at presentation when compared with clopidogrel. There are no significant differences between the two newer drugs. As the drugs were mainly used during three consecutive periods, unmeasured confounding related to the development of cardiac care and changes in the population may contribute to the results." @default.
- W3171692612 created "2021-06-22" @default.
- W3171692612 creator A5011946702 @default.
- W3171692612 creator A5026481024 @default.
- W3171692612 creator A5032375628 @default.
- W3171692612 creator A5081478760 @default.
- W3171692612 creator A5081986241 @default.
- W3171692612 creator A5085852635 @default.
- W3171692612 creator A5087842948 @default.
- W3171692612 creator A5088039325 @default.
- W3171692612 date "2021-06-08" @default.
- W3171692612 modified "2023-10-17" @default.
- W3171692612 title "Prehospital Adenosine Diphosphate Receptor Blocker Use, Culprit Artery Flow, and Mortality in STEMI: The MADDEC Study" @default.
- W3171692612 cites W1409766979 @default.
- W3171692612 cites W2054113896 @default.
- W3171692612 cites W2068493362 @default.
- W3171692612 cites W2091107667 @default.
- W3171692612 cites W2091709324 @default.
- W3171692612 cites W2104595603 @default.
- W3171692612 cites W2110108344 @default.
- W3171692612 cites W2131184211 @default.
- W3171692612 cites W2131226493 @default.
- W3171692612 cites W2140501627 @default.
- W3171692612 cites W2150740314 @default.
- W3171692612 cites W2168874562 @default.
- W3171692612 cites W2169387542 @default.
- W3171692612 cites W2211414126 @default.
- W3171692612 cites W2511494980 @default.
- W3171692612 cites W2752033985 @default.
- W3171692612 cites W2754054868 @default.
- W3171692612 cites W2785722517 @default.
- W3171692612 cites W2919641900 @default.
- W3171692612 cites W2941013735 @default.
- W3171692612 cites W2945659745 @default.
- W3171692612 cites W2954511551 @default.
- W3171692612 cites W2971165578 @default.
- W3171692612 cites W2991357112 @default.
- W3171692612 cites W3011767589 @default.
- W3171692612 cites W565102732 @default.
- W3171692612 cites W2625362162 @default.
- W3171692612 doi "https://doi.org/10.1007/s40261-021-01045-2" @default.
- W3171692612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8245391" @default.
- W3171692612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34101137" @default.
- W3171692612 hasPublicationYear "2021" @default.
- W3171692612 type Work @default.
- W3171692612 sameAs 3171692612 @default.
- W3171692612 citedByCount "1" @default.
- W3171692612 countsByYear W31716926122022 @default.
- W3171692612 crossrefType "journal-article" @default.
- W3171692612 hasAuthorship W3171692612A5011946702 @default.
- W3171692612 hasAuthorship W3171692612A5026481024 @default.
- W3171692612 hasAuthorship W3171692612A5032375628 @default.
- W3171692612 hasAuthorship W3171692612A5081478760 @default.
- W3171692612 hasAuthorship W3171692612A5081986241 @default.
- W3171692612 hasAuthorship W3171692612A5085852635 @default.
- W3171692612 hasAuthorship W3171692612A5087842948 @default.
- W3171692612 hasAuthorship W3171692612A5088039325 @default.
- W3171692612 hasBestOaLocation W31716926121 @default.
- W3171692612 hasConcept C126322002 @default.
- W3171692612 hasConcept C156957248 @default.
- W3171692612 hasConcept C164705383 @default.
- W3171692612 hasConcept C2777028646 @default.
- W3171692612 hasConcept C2777698277 @default.
- W3171692612 hasConcept C2777849778 @default.
- W3171692612 hasConcept C2778826181 @default.
- W3171692612 hasConcept C2780400711 @default.
- W3171692612 hasConcept C2780890252 @default.
- W3171692612 hasConcept C45393284 @default.
- W3171692612 hasConcept C500558357 @default.
- W3171692612 hasConcept C71924100 @default.
- W3171692612 hasConceptScore W3171692612C126322002 @default.
- W3171692612 hasConceptScore W3171692612C156957248 @default.
- W3171692612 hasConceptScore W3171692612C164705383 @default.
- W3171692612 hasConceptScore W3171692612C2777028646 @default.
- W3171692612 hasConceptScore W3171692612C2777698277 @default.
- W3171692612 hasConceptScore W3171692612C2777849778 @default.
- W3171692612 hasConceptScore W3171692612C2778826181 @default.
- W3171692612 hasConceptScore W3171692612C2780400711 @default.
- W3171692612 hasConceptScore W3171692612C2780890252 @default.
- W3171692612 hasConceptScore W3171692612C45393284 @default.
- W3171692612 hasConceptScore W3171692612C500558357 @default.
- W3171692612 hasConceptScore W3171692612C71924100 @default.
- W3171692612 hasFunder F4320311795 @default.
- W3171692612 hasFunder F4320321108 @default.
- W3171692612 hasFunder F4320322550 @default.
- W3171692612 hasFunder F4320322861 @default.
- W3171692612 hasFunder F4320323333 @default.
- W3171692612 hasFunder F4320324052 @default.
- W3171692612 hasFunder F4320328021 @default.
- W3171692612 hasFunder F4320328501 @default.
- W3171692612 hasFunder F4320335254 @default.
- W3171692612 hasIssue "7" @default.
- W3171692612 hasLocation W31716926121 @default.
- W3171692612 hasLocation W31716926122 @default.
- W3171692612 hasOpenAccess W3171692612 @default.
- W3171692612 hasPrimaryLocation W31716926121 @default.
- W3171692612 hasRelatedWork W2316757300 @default.
- W3171692612 hasRelatedWork W2369639111 @default.